Komori
Daiken Medical (7775) · RiskFirst stated

Foreign Exchange Risk Arising from Import and Export Transactions

First written in FY2025. . Latest entry: FY2025.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Earnings impact from exchange-rate fluctuations and foreign-currency-denominated transactionsA theme 480 companies write about · 418 as a headwind · 20 as a tailwind

The whole theme swung hardest in 2025: 71 of 159 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 195 companies compared. The sentences above are computed from all 195.Comparing 200 of the theme's 494 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025First statedAnnual report

    「現時点において、当社の海外売上比率は3.2%であり為替変動の影響は限定的でありますが、今後輸出取引が増えると為替リスクが高まる可能性があります。」

    輸出販売・輸入仕入における外貨建取引の為替変動リスクを新たに独立項目として記載している。為替リスク管理規程、為替予約等によるヘッジと、サプライチェーン高度化・生産効率化による調達コスト削減を対応策としている。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Daiken Medical's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Foreign Exchange Risk Arising from Import and Export Transactions | DAIKEN MEDICAL CO.,LTD. (7775) | Komori